Pricing Log in Create free account
Saturday 17 October 2026 Export CRL’s income statement to Excel — free account

Charles River Laboratories International, Inc.

CRL Healthcare Diagnostics & Research

Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024. In the quarter to June 2026, revenue fell 2.72%, EPS fell 102.8%, free cash flow fell 12.2% and total debt rose 12.3%, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

299.77 6.47 −2.11%
Market cap
$14.6B
P/E
0.0×
Fwd P/E
29.6×
Dividend yield
—
F-score
5/9
Altman Z
2.40
Beneish M
−3.11
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Charles River Laboratories International, Inc. (CRL) Book value per share

Alert me on Book value per share

Charles River Laboratories International, Inc.'s book value per share at the end of fiscal 2025 was 64.0×, down 5.22% from 67.5× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 59.3×. Over the past ten years it has ranged from 15.9× (fiscal 2015) to 70.3× (fiscal 2023); the current reading is higher than 82% of that period. Charles River Laboratories International, Inc. ranks 8th of 52 Diagnostics & Research companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 64.0× (5.22%)
FY2024 67.5× (4.04%)
FY2023 70.3× 19.86%
FY2022 58.7× 16.21%
FY2021 50.5× 18.10%
FY2020 42.7× 27.19%
FY2019 33.6× 22.10%
FY2018 27.5× 24.78%
FY2017 22.1× 23.59%
FY2016 17.8× 12.52%

Quarterly newest first

Period Book value per share Change
Jun 2026 59.3× (1.54%)
Mar 2026 60.2× (5.89%)
Dec 2025 64.0× (7.71%)
Sep 2025 69.3× 1.38%
42 more quarters

Against its own ten years

Low 15.9× High 70.3×
Ten-year median 42.7×
Current reading's percentile 82

Book value per share against peers

Company Book value per share
ICLR ICON PLC compare 122×
LH Labcorp Holdings Inc. compare 105×
DGX Quest Diagnostics Incorporated compare 70.4×
RVTY Revvity Inc. compare 64.8×
CRL Charles River Laboratories International, Inc. 59.3×
QGEN QIAGEN N.V. compare 16.3×
MEDP Medpace Holdings, Inc. compare 15.4×
TWST Twist Bioscience Corporation compare 7.1×
GH Guardant Health, Inc. compare −1.7×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on CRL